Search research articles
Contact Us
Filters
Showing results (11-20 of 707) with videos related to
Page
of 71
Sort By:
The Journal of Clinical Psychiatry
|
February 4, 1998
Antipsychotic agents and bipolar disorder
M Tohen, C A Zarate
Biological Psychiatry
|
October 16, 2010
Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?
Giacomo Salvadore, Carlos A Zarate
Case Reports in Genetics
|
August 9, 2020
Managing Sleep and Behavioral Problems in a Preschooler with <i>SATB2</i>-Associated Syndrome
Nihit Kumar, Yuri A Zarate
Current Psychiatry Reports
|
November 5, 2008
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder
Nancy DiazGranados, Carlos A Zarate
Acta Neurologica Belgica
|
February 2, 2019
Widening phenotypic spectrum of GABBR2 mutation
Debopam Samanta, Yuri A Zarate
Clinical Endocrinology
|
October 1, 1987
The significance of elevated levels of gastrin in patients with pituitary adenoma
M E Fonseca, A Zarate
The American Journal of Psychiatry
|
January 2, 2004
Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients
Carlos A Zarate, Mauricio Tohen
Current Psychiatry Reports
|
January 29, 2008
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
Sungho Maeng, Carlos A Zarate
The Journal of Clinical Psychiatry
|
March 1, 2000
Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study
C A Zarate, M Tohen
Archives of General Psychiatry
|
December 26, 2001
Sudden cardiac death and antipsychotic drugs: do we know enough?
C A Zarate, J Patel
Page
of 71
Search research articles
Search
Showing results (11-20 of 707) with videos related to
Sort By:
Page
of 71
The Journal of Clinical Psychiatry
|
February 4, 1998
Antipsychotic agents and bipolar disorder
M Tohen, C A Zarate
Biological Psychiatry
|
October 16, 2010
Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?
Giacomo Salvadore, Carlos A Zarate
Case Reports in Genetics
|
August 9, 2020
Managing Sleep and Behavioral Problems in a Preschooler with <i>SATB2</i>-Associated Syndrome
Nihit Kumar, Yuri A Zarate
Current Psychiatry Reports
|
November 5, 2008
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder
Nancy DiazGranados, Carlos A Zarate
Acta Neurologica Belgica
|
February 2, 2019
Widening phenotypic spectrum of GABBR2 mutation
Debopam Samanta, Yuri A Zarate
Clinical Endocrinology
|
October 1, 1987
The significance of elevated levels of gastrin in patients with pituitary adenoma
M E Fonseca, A Zarate
The American Journal of Psychiatry
|
January 2, 2004
Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients
Carlos A Zarate, Mauricio Tohen
Current Psychiatry Reports
|
January 29, 2008
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
Sungho Maeng, Carlos A Zarate
The Journal of Clinical Psychiatry
|
March 1, 2000
Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study
C A Zarate, M Tohen
Archives of General Psychiatry
|
December 26, 2001
Sudden cardiac death and antipsychotic drugs: do we know enough?
C A Zarate, J Patel
Page
of 71